Skip to main content
. 2021 Oct 31;14(11):1120. doi: 10.3390/ph14111120
Ach Acetylcholine
2-AG 2-Arachidonoylglycerol
AEA Anandamide
ANOVA Analysis of variance
BP Blood pressure
Cnr1 Cannabinoid receptor 1 protein coding gene
Cnr2 Cannabinoid receptor 2 protein coding gene
COX Cyclooxygenase
CRCs Concentration response curves
CBD Cannabidiol
DMF N,N-Dimethylformamide
DEA Docosatetraenoyl ethanolamide
DHEA Docosahexaenoyl ethanolamide
eNOS Endothelial nitric oxide synthase
EPEA Eicosapentaenoyl ethanolamide
FAAH Fatty acid amide hydrolase
HEA Homo-γ-linolenyl ethanolamide
HR Heart rate
LEA Linolenoyl ethanolamide
2-LG Linoleoylglycerol
i.p. Intraperitoneally
KCa3.1 Intermediate potassium calcium-activated channel
KCa2.3 Small potassium calcium-activated channel
KCNN3 Potassium calcium-activated channel subfamily N member 3 protein coding gene
KCNN4 Potassium calcium-activated channel subfamily N member 4 protein coding gene
kDA Kilodaltons
LC-MS Ultrahigh performance liquid chromatography-tandem mass spectrometry
L-NAME NG-Nitro-L-arginine methyl ester
MRM Multiple reaction monitoring
NAGly N-Arachidonoyl glycine
N.D. Not determined
NO Nitric oxide
OEA Oleoyl ethanolamide
PEA Palmitoyl ethanolamide
POEA Palmitoleoyl ethanolamide
PGIS Prostaglandin I2 synthase protein coding gene
Phe Phenylephrine
PPAR Peroxisome proliferator-activated receptors
RIPA Radioimmunoprecipitation assay
RT-PCR Real time reverse transcription-polymerase chain reaction
SBP Systolic blood pressure
SHAM Sham operated Wistar rats
SHR Spontaneously hypertensive rats
SNP Sodium nitroprusside
SOD Superoxide dismutase
SEA Stearoyl ethanolamide
TRPV1 Transient receptor potential vanilloid type 1
vWF Von Willebrand factor
WKY Wistar Kyoto Rats
ZDF Zucker Diabetic Fatty rats